Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

133 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cytotoxic human CD4(+) T cells.
van de Berg PJ, van Leeuwen EM, ten Berge IJ, van Lier R. van de Berg PJ, et al. Among authors: van leeuwen em, van lier r. Curr Opin Immunol. 2008 Jun;20(3):339-43. doi: 10.1016/j.coi.2008.03.007. Epub 2008 Apr 24. Curr Opin Immunol. 2008. PMID: 18440213 Review.
Pharmacodynamics of rituximab in paediatric immune mediated diseases: B cell depletion and repopulation, effects on immunoglobulin levels and risk for infections.
Nassar-Sheikh Rashid A, Bergkamp SC, Kampinga RE, Gouw SC, Bouts AHM, Oosterveld MJS, Baars PA, van Leeuwen EMM, Kuijpers TW, van den Berg JM, Schonenberg-Meinema D. Nassar-Sheikh Rashid A, et al. Among authors: van leeuwen emm. Clin Exp Rheumatol. 2023 Nov;41(11):2323-2330. doi: 10.55563/clinexprheumatol/yqjz1s. Epub 2023 Jul 13. Clin Exp Rheumatol. 2023. PMID: 37470239 Free article.
Does COVID-19 impact the prevalence of myositis specific antibodies in the Netherlands? A comparative nationwide study.
Kamperman RG, van Leeuwen EM, Willems M, van der Kooi AJ, Gelderman KA, Hamann D, van Lochem EG, Meek B, van der Molen RG, Platteel AC, Otten HG, Schreurs MW; Dutch Myositis Network; Raaphorst J. Kamperman RG, et al. Among authors: van leeuwen em. J Autoimmun. 2023 Sep;139:103081. doi: 10.1016/j.jaut.2023.103081. Epub 2023 Jun 12. J Autoimmun. 2023. PMID: 37393780 No abstract available.
Fourth mRNA COVID-19 vaccination in immunocompromised patients with haematological malignancies (COBRA KAI): a cohort study.
Hofsink Q, Haggenburg S, Lissenberg-Witte BI, Broers AEC, van Doesum JA, van Binnendijk RS, den Hartog G, Bhoekhan MS, Haverkate NJE, van Meerloo J, Burger JA, Bouhuijs JH, Smits GP, Wouters D, van Leeuwen EMM, Bontkes HJ, Kootstra NA, Vogels-Nooijen S, Rots N, van Beek J, Heemskerk MHM, Groen K, van Meerten T, Mutsaers PGNJ, van Gils MJ, Goorhuis A, Rutten CE, Hazenberg MD, Nijhof IS; COBRA KAI study team. Hofsink Q, et al. Among authors: van leeuwen emm. EClinicalMedicine. 2023 Jul;61:102040. doi: 10.1016/j.eclinm.2023.102040. Epub 2023 Jun 15. EClinicalMedicine. 2023. PMID: 37337616 Free PMC article.
Megalobastic anemia, infantile leukemia, and immunodeficiency caused by a novel homozygous mutation in the DHFR gene.
Kuijpers TW, de Vries ACH, van Leeuwen EM, Ermens ATAM, de Pont S, Smith DEC, Wamelink MMC, Mensenkamp AR, Nelen MR, Lango Allen H, Pals ST, Beverloo BHB, Huidekoper HH, Wagner A. Kuijpers TW, et al. Among authors: van leeuwen em. Blood Adv. 2022 Nov 22;6(22):5829-5834. doi: 10.1182/bloodadvances.2022007233. Blood Adv. 2022. PMID: 35977078 Free PMC article. No abstract available.
133 results